Novel Cannabinergic Compounds And Uses Thereof
US-2019185443-A1 · Jun 20, 2019 · US
US10968206B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10968206-B2 |
| Application number | US-201916240190-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 4, 2019 |
| Priority date | Feb 26, 2013 |
| Publication date | Apr 6, 2021 |
| Grant date | Apr 6, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present technology relates to novel cannabinergic nitrate esters and related analogs, process of preparation, pharmaceutical compositions and their methods of use as medicaments, pharmacological tools and/or biomarkers. The novel cannabinergic nitrate ester compounds provide medicaments useful in treating a variety of diseases and medical disorders.
Opening claim text (preview).
What is claimed is: 1. A compound of formula (IIa): or a pharmaceutically acceptable salt thereof; wherein: ring C is carbocyclic, bicyclic, aryl, heterocyclyl, heteroaryl, or a terpene; G is a bond, C═O, NH, CH 2 , CONN, NHCO, C(O)O, OC(O), OCH 2 , S, SO, SO 2 , or O; ring A is: R 2a and R 2b are each independently H, OH, SH, NH 2 , CF 3 , COOH, alkoxy, halogen, ONO 2 , alkyl-ONO 2 , or optionally substituted alkyl, haloalkyl, amine, amide, imide, alkoxy, alkoxy thio, phosphate, phosphonate, carboxyl, formyl, carbamyl, amino, acylamino, amido, imido, aminoalkyl, aminoaryl, heteroarylamino, heterocyclylamino, sulfonate, sulfonamide, sulfonyl, thioalkyl, thioaryl, heteroarylthio, heterocyclylthio, phosphonate, phosphate, or acetate; Y is a bond; and R 3 is alkyl, wherein the carbocyclic, bicyclic, aryl, heterocyclyl, or heteroaryl Ring C is optionally substituted with one or more substituents selected from alkyl, alkynyl, alkenyl, alcohol, halogen, hydroxyl, alkoxy, alkenoxy, alkynoxy, aryloxy, aralkyloxy, heterocyclyloxy, heterocyclylalkoxy, oxo, carboxyl, ester, urethane, oxime, hydroxylamine, alkoxyamine, aralkoxyamine, thiol, sulfide, sulfoxide, sulfone, sulfonyl, sulfonamide, amine, N-oxide, hydrazine, hydrazide, hydrazine, azide, amide, urea, amidine, guanidine, enamine, imide, isocyanate, isothiocyanate, cyanate, thiocyanate, imine, nitro, or nitrile. 2. The compound of claim 1 , wherein ring C is: 3. The compound of claim 1 , wherein: ring C is carbocyclic or heterocyclyl; ring A is heteroaromatic; G is C═O or CONH; and R 2a and R 2b are each independently Cl, OH, O-alkyl, alkyl, amino, thio, O(CO)alkyl, or OC(O)NH 2 . 4. The compound of claim 1 , wherein: C is aromatic and A is heteroaromatic, and G is C═O; C is aromatic and A is heteroaromatic, and G is CONH; C is heterocyclic and A is heteroaromatic, and G is C═O; C is carbocyclic and A is heteroaromatic, and G is C═O; C is aromatic and A is heteroaromatic, and G is NH; C is a terpene; C is carbocyclic; C is heteroaromatic and A is heteroaromatic, and G is OCH 2 ; C is aromatic and A is heterocyclic, and G is CH 2 ; C is carbocyclic and A is heteroaromatic, and G is a COO or OCO; C is heterocyclic and A is heteroaromatic, and G is a bond; C is aromatic and A is heterocyclic, and G is a bond; or C is bicyclic. 5. A compound represented by one of the following structural formulas: or a pharmaceutically acceptable salt thereof. 6. A composition comprising a compound of claim 1 , or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable excipient. 7. A compound represented by the following structural formula: or a pharmaceutically acceptable salt thereof. 8. The compound of claim 1 , wherein ring A is:
o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol · CPC title
having nitrate groups bound to acyclic carbon atoms · CPC title
Ring systems having three or more relevant rings · CPC title
having six-membered rings with one nitrogen as the only ring hetero atom · CPC title
the bicyclo ring system containing seven carbon atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.